HIMS
Hims Hers Health Inc
$26.98
+14.95%
Price vs EBIT Yield
Current Valuation
- EBIT Yield
- 1.10%
- EV/EBIT
- 90.5x
- P/E Ratio
- 46.0x
- PEG Ratio
- 2.61
EV/EBIT Averages
- Median (Fair Value)
- 165.1x
- Industry (Damodaran)
- 20.3x
- 1-Year Avg
- 90.5x
- 3-Year Avg
- 78.5x
- 5-Year Avg
- 71.6x
- Min / Max
- 54.7x / 261.7x
EBIT Growth
- YoY Growth
- 310.2%
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- Current Margin
- 4.2%
Financial Snapshot
- Market Cap
- $5.35B
- Enterprise Value
- $5.89B
- Revenue (TTM)
- $2.35B
- Dividend Yield
- -
Valuation Context
vs 5-Year Average
26%
Above average (potentially overvalued)
EBIT Yield
1.10%
Below average yield
vs Industry (Drugs (Pharmaceutica...)
345%
Above industry avg
Data Points
250
daily data points